Shropshire Kenneth 4

What Happened

• Kenneth Shropshire, a director of Moelis & Co (MC), was granted a total of 1,900 restricted stock units (RSUs) on July 1, 2026: 1,700 RSUs (2026 Annual RSUs) and 200 RSUs (2026 Elective RSUs). The grants are reported as awards (transaction code A).
• The company used a per-share valuation of $64.68 (five‑day NYSE average ended June 30, 2026), giving an approximate grant value of $122,892. Each RSU represents the right to receive one share of Class A common stock.

Key Details

• Transaction date: July 1, 2026; Form 4 filed July 6, 2026 (filed five days after the transaction date; note Form 4s are typically due within two business days).
• Per-share valuation used for the grant: $64.68; total RSUs granted: 1,900 (1,700 + 200). Approximate grant value: $122,892.
• Shares owned after the transaction: not specified in the provided filing.
• Notable footnotes:
  • F1: 1 RSU = right to 1 share.
  • F2: The 2026 Annual RSUs vested on July 1, 2026 but settlement is delayed — within 60 days following July 1, 2028.
  • F4: The 2026 Elective RSUs vest in equal fourths at the beginning of each quarter ending July 1, 2027, with settlement within 60 days after each vesting date.
  • F3: Grants were to a non‑employee director and valued using the five‑day average closing price.

Context

• RSU awards are compensation (not open‑market purchases or sales). Vesting and delayed settlement mean Shropshire does not immediately receive tradable shares; these RSUs convert to shares (or equivalent) only at the stated settlement dates.
• Because this is a director compensation grant to a non‑employee director, it is a routine award rather than evidence of an open‑market buy or sell.